Management of patients with ovarian cancer in the COVID‐19 era
Giorgio Bogani, Jvan Casarin, Ciro Pinelli, Violante Di Donato, Sara Bosio, Simona Ruisi, Claudia Brusadelli, Rocco Guerrisi, Giuseppe Sarpietro, Antonino Ditto, Fabio Ghezzi, Francesco Raspagliesi
Abstract
At the beginning of 2020, coronavirus disease 2019 (COVID-19) spreads worldwide. Patients with ovarian cancer should be considered at high-risk of developing severe morbidity related to COVID-19. Most of them are diagnosed in advanced stages of disease, and they are fragile. Here, we evaluated the major impact of COVID-19 on patients with ovarian cancer, discussing the effect of the outbreak on medical and surgical treatment.
Topics & Concepts
MedicineCoronavirus disease 2019 (COVID-19)Ovarian cancerOutbreakDisease2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)CancerIntensive care medicineInternal medicineOncologyInfectious disease (medical specialty)PathologyCOVID-19 and healthcare impactsInfection Control and VentilationCOVID-19 Impact on Reproduction